T he study of ordered mesoporous silica materials has exploded since their discovery by Mobil researchers 20 years ago. The ability to make uniformly sized, porous, and dispersible nanoparticles using colloidal chemistry and evaporation-induced self-assembly has led to many applications of mesoporous silica nanoparticles (MSNPs) as "nanocarriers" for delivery of drugs and other cargos to cells. The exceptionally high surface area of MSNPs, often exceeding 1000 m 2 /g, and the ability to independently modify pore size and surface chemistry, enables the loading of diverse cargos and cargo combinations at levels exceeding those of other common drug delivery carriers such as liposomes or polymer conjugates. This is because noncovalent electrostatic, hydrogen-bonding, and van der Waals interactions of the cargo with the MSNP internal surface cause preferential adsorption of cargo to the MSNP, allowing loading capacities to surpass the solubility limit of a solution or that achievable by osmotic gradient loading. The ability to independently modify the MSNP surface and interior makes possible engineered biofunctionality and biocompatibility.
T he study of ordered mesoporous silica materials has exploded since their discovery by Mobil researchers 20 years ago. The ability to make uniformly sized, porous, and dispersible nanoparticles using colloidal chemistry and evaporation-induced self-assembly has led to many applications of mesoporous silica nanoparticles (MSNPs) as "nanocarriers" for delivery of drugs and other cargos to cells. The exceptionally high surface area of MSNPs, often exceeding 1000 m 2 /g, and the ability to independently modify pore size and surface chemistry, enables the loading of diverse cargos and cargo combinations at levels exceeding those of other common drug delivery carriers such as liposomes or polymer conjugates. This is because noncovalent electrostatic, hydrogen-bonding, and van der Waals interactions of the cargo with the MSNP internal surface cause preferential adsorption of cargo to the MSNP, allowing loading capacities to surpass the solubility limit of a solution or that achievable by osmotic gradient loading. The ability to independently modify the MSNP surface and interior makes possible engineered biofunctionality and biocompatibility.
In this Account, we detail our recent efforts to develop MSNPs as biocompatible nanocarriers ( Figure 1 ) that simultaneously display multiple functions including (1) high visibility/contrast in multiple imaging modalities, (2) dispersibility, (3) binding specificity to a particular target tissue or cell type, (4) ability to load and deliver large concentrations of diverse cargos, and (5) triggered or controlled release of cargo. Toward function 1, we chemically conjugated fluorescent dyes or incorporated magnetic nanoparticles to enable in vivo optical or magnetic resonance imaging. For function 2, we have made MSNPs with polymer coatings, charged groups, or supported lipid bilayers, which decrease aggregation and improve stability in saline solutions. For functions 3 and 4, we have enhanced passive bioaccumulation via the enhanced permeability and retention effect by modifying the MSNP surfaces with positively charged polymers. We have also chemically attached ligands to MSNPs that selectively bind to receptors overexpressed in cancer cells. We have used encapsulation of MSNPs within reconfigurable supported lipid bilayers to develop new classes of responsive nanocarriers that actively interact with the target cell. Toward function 4, we exploit the high surface area and tailorable surface chemistry of MSNPs to retain hydrophobic drugs. Finally, for function 5, we have engineered dynamic behaviors by incorporating molecular machines within or at the entrances of MSNP pores and by using ligands, polymers, or lipid bilayers. These provide a means to seal-in and retain cargo and to direct MSNP interactions with and internalization by target cells.
Application of MSNPs as nanocarriers requires biocompatibility and low toxicity. Here the intrinsic porosity of the MSNP surface reduces the extent of hydrogen bonding or electrostatic interactions with cell membranes as does surface coating with polymers or lipid bilayers. Furthermore, the high surface area and low extent of condensation of the MSNP siloxane framework promote a high rate of dissolution into soluble silicic acid species, which are found to be nontoxic. Potential toxicity is further mitigated by the high drug capacity of MSNPs, which greatly reduces needed dosages compared with other nanocarriers. We anticipate that future generations of MSNPs incorporating molecular machines and encapsulated by membrane-like lipid bilayers will achieve a new level of controlled cellular interactions.
Introduction
History of Mesoporous Silica Nanoparticles (MSNPs). In their classic paper, Kresge and co-workers 1 
Methods of MSNP Modification
Chemical Modification. MSNP functionality can be introduced by modifying silanol groups present both within the pore interiors and on the outer surface. These groups are chemically accessible and can be easily reacted with alkoxysilane derivatives to introduce organic functionality. Chemical moieties can also be adsorbed onto MSNP, especially facilitated by negatively charged SiO À groups, resulting from deprotonation of surface silanol groups at neutral pH, which result in attractive electrostatic interactions with positively charged mioieties ( Figure 1 ). Generally, two main routes of modification exist: co-condensation, and postsynthetic grafting.
Co-condensation. The co-condensation method involves co-condensing hydrolyzed alkoxysilanes with organoalkoxy-
, which results in a directed modification of the interior pore surface. 12 The amphiphilic nature of the hydrolyzed organosilane allows it to serve as a cosurfactant that is incorporated into the surfactant micelle. As silica is condensed, the organoalkoxysilane is co-condensed positioning the organic moiety directly onto the pore walls. An extension of the co-condensation method is the synthesis of MSNPs surrounding metal or metal oxide nanoparticles in a coreÀshell architecture ( Figure 2 ). 13 CoreÀ
shell MSNPs have seen many recent applications in theranostics. the combination of therapy and diagnostics.
14 Postsynthetic Grafting. A second method, postsynthetic grafting, involves modification of MSNPs after synthesis. This method employs surface-accessible silanol groups both within the mesopore network and on the exterior MSNP surfaces. Maximal surface coverage of interior mesopores is achieved via condensation with trifunctional organosilanes R 0 Si(OR) 3 in an organic solvent and produces a selfassembled monolayer. 15 To restrict or bias the deposition to the exterior surface of the MSNP, the modification can be performed prior to extracting the templating agent. The templating agent can then be removed, and the protected, unreacted silanol groups in the pore interiors can be further modified. In this way, functionalization can be directed. The various types of MSNP modifications and their strategies for synthesis are summarized in 
Modified MSNPs for Biological Applications
A burgeoning area of MSNP research has been their use as nanocarriers in biology. 28 Consequently, much of our present work has been directed toward tailoring MSNP properties in order to improve their biofunctionality and biocompatibility. To be effective and universally applicable, nanocarriers must simultaneously demonstrate multiple functions and characteristics including (1) ease of imaging, (2) dispersibility, (3) specificity, (4) ability to load and deliver large concentrations of diverse cargos, and (5) isothiocyanate (FITC) and rhodamine B isothiocyanate (RITC) are the most common fluorescent compounds that are incorporated into the MSNP core. Near-IR dyes, such as AlexaFluor 700 and DyLight 680, have also been used in MSNPs for imaging. This type of fluorescent labeling is fairly robust and can be easily achieved. The resulting fluorescent MSNPs are capable of generating high-resolution, multichannel images and can also provide quantitative data using flow cytometry techniques. 16 As an example, Figure 5a shows eight channel hyperspectral confocal images of four fluorescently labeled cargo classes delivered using targeted protocells. Colocalization of the cargo, silica, and lipid after 15 min is consistent with a receptor-mediated endocytotic pathway ( Figure 6 ). 19 After 12 hours (Figure 5b ), pH-triggered cargo release and endosomal disruption delivers the cargo into the cytosol.
Another relatively new method of imaging MSNPs is to incorporate magnetic nanoparticles, e.g., magnetite Fe 3 O 4 , as cores of the MSNPs, which allows T 2 -weighted MRI imaging. 16 Alternatively, T 1 -weighted imaging can be achieved using a chelated gadolinium compound. 22 Dispersibility. For their use in biomedical applications, MSNPs must remain highly dispersed requiring colloidal stability. If aggregated, cell internalization suffers, biodistribution is difficult to control, and larger effective particle sizes may lead to potentially higher toxicity (see MSNP Toxicity). Particle agglomeration can be reduced by chemically modifying the surfaces, 23 introducing surface coatings with proteins or polymers, 6 and coating with a supported lipid bilayer. 19À21 These methods provide steric hindrance and electrostatic repulsion to achieve stable saline dispersions of MSNPs. In terms of passive targeting, Xia et al. demonstrated that cationic polymer (PEI) coating of MSNPs significantly facilitates their uptake. 17 Meng et al. showed that through combined size control and PEI/PEG copolymer coating, an enhanced EPR effect can be observed on a xenograft model. 6 Active targeting employs ligands that bind specifically to receptors overexpressed on the cancer cell surface. Bioactive ligands, such as folate, RGD peptide, and transferrin have been employed 26 due to their respective receptors being overexpressed on many different cancer cell types. In general, high specificity and binding affinity require a high concentration of surface-conjugated ligands to promote multivalent binding effects, which result in more efficient drug delivery through receptor-mediated internalization pathways ( Figure 6 ). However, high ligand densities can promote nonspecific interactions with endothelial and other noncancerous cells and increase immunogenicity, resulting in opsonization-mediated clearance of nanocarriers. In this regard, the MSNP supported lipid bilayer construct (protocell) provides some potential advantages because its fluid SLB enables targeting ligand recruitment to target cell surface receptors, promoting high avidity with a low overall peptide concentration ( Figure 7) . Cargo Loading and Delivery. The high surface area and controllable chemistry of the MSNPs allow for simple loading of high concentrations 12, 19, 20 of diverse classes and combination of cargos that can be delivered by endocytosis ( Figure 6 ) or macropinocytosis. Early studies of drug delivery using MSNPs focused on drugs exhibiting low solubility in water, in particular, ibuprofen and aspirin. 27 Lu and Liong et al. later demonstrated the delivery of a hydrophobic chemotherapeutic agent, camptothecin, into cancer cells using MSNPs. 23 The high pore volume and surface area of MSNPs allows hydrophobic compounds to be loaded into the pores from a nonaqueous solution and be retained in aqueous environments. When MSNPs are internalized through endocytosis ( Figure 6 ), it is envisioned that lipid membrane components facilitate the phase transfer of the stored hydrophobic payload enabling it to be gradually released. When a hydrophilic cargo is involved, further modification of the MSNPs is often required. Meng and Liong et al.
attached negatively charged groups onto MSNPs to enable the loading and retention of the positively charged hydrophilic drug, doxorubicin (DOX). 18 Compared with FDAapproved Doxil, the doxorubicin capacity in MSNPs can be nearly 1000 times greater due to the high surface area and attractive electrostatic interactions. 19 For most nanocarrier delivery strategies, the cargo must be retained within the nanocarrier and released only upon delivery to the target cell. For MSNPs, this generally requires that either the cargo be strongly adsorbed, as for DOX described above, or that the pores be "sealed" after cargo loading. A method where quantum dots and small nanoparticles (caps) were used to block the entrance of pores was developed. 28 Numerous strategies have been demonstrated where, by constructing a supramolecular nanovalve on the outer surface of MSNPs, one can achieve controlled release via a variety of stimuli, such as pH change, enzymatic ligand cleavage, light, and externally applied magnetic fields.
29À32
Polymer coatings 33 or supported lipid bilayers 19À21 have also been proven effective in sealing cargos within MSNPs, where in the latter case endosome-disrupting peptides were used to achieve pH-triggered cargo release into the cytosol.
Toxicity
MSNP Toxicity. A critical issue for any nanocarrier application is nanoparticle toxicity. The toxicity of silicon dioxide, both crystalline and amorphous, has been studied for more than a century, especially as it relates to silicosis, 34À37 and recently, the toxicity of silica nanoparticles has been extensively investigated, because the high surface to volume ratio of nanoparticles could lead to enhanced cellular interactions and different pathways of toxicity compared with coarsegrained silica. 6 Despite hundreds of studies of the toxicity of amorphous and crystalline silicas, 34À37 the mechanism(s) by which silica exposure leads to silicosis remains unclear, and literature reports are at times contradictory. Here it should be emphasized that all silica is not created equal. The amorphous silica framework and surface chemistry, in particular, hydroxyl coverage 38 and size and distribution of siloxane rings that comprise the framework structure, 39 can result in a wide range of configurations depending on processing conditions and environmental exposure. Consequently, there have been widely differing reports concerning the toxicity of MSNPs and amorphous silica in general. 7,40À42 There is, however, a general consensus that toxicity is associated in part with surface silanol (tSiOH) groups, 43 which can hydrogen bond to membrane components 44 or when dissociated to form SiO À (above the isoelectric point of silica ∼pH 2À3), interact electrostatically with the positively charged tetraalkylammonium-containing phospholipids, 44 both processes leading to strong interactions and possibly membranolysis. Such a process occurring at the cell surface could cause lysis, for example, hemolysis, as shown for red blood cells. 7, 42, 44 Within a phagosome, damage to the membrane could cause release of hydrolytic enzymes from lysosomes into the cytoplasm.
In support of the importance of silanols, it is known that treating the silica surface with poly(vinylpyridine-N-oxide), aluminum salts, or surfactants can reduce or even switch-off hemolysis of red blood cells. 44 Based on the high surface to volume ratio of silica NPs, it might be anticipated that they would show in general higher toxicity compared with their bulk counterparts. However in the case of mesoporous silica NPs, the reduced solid fraction of the MSNP surface serves to reduce the surface area normalized hydroxyl coverage and therefore the extent of hydrogen bonding and electrostatic interactions between the MSNP and the cell membrane. 43 Additionally, based on membrane curvature arguments, very small NPs are less likely to disrupt or become internalized by the cell membrane 43 because the membrane binding energy needed for the cell membrane to contact and fully envelop the NP scales quadratically with the NP curvature (1/diameter). A second contribution to toxicity can be the reaction of radicals present on the silica surface with water to yield reactive oxygen species (ROS), in particular, the hydroxy radical HO
• , one of the most reactive species in nature. 45 ROS can cause cell death by disrupting cell membranes (necrosis) or initiating programmed cell death (apoptosis). In sublethal concentrations, ROS can upregulate production of cytokines and other inflammatory mediators and can promote mutagenesis and carcinogenesis. Although the ability of freshly ground crystalline silicas to serve as generators of ROS is generally recognized and has been linked to traces of iron suggesting a Fenton-like mechanism, the ability of iron-free and amorphous silicas to generate ROS is just beginning to be appreciated. 46 Here it is noteworthy that depending on processing conditions, amorphous silicas can contain significant populations of strained three-membered siloxane rings. 47, 39 Strained siloxane rings could undergo homolytic cleavage to form surface-associated radicals including the nonbridging oxygen hole center, 48 which react exothermically with water to form hydroxy radicals. 45 Whether, like defects generated by grinding of crystalline silica, strained three-membered rings in amorphous silica could serve as ROS generators is a question we are currently addressing. 39 Notably, as-synthesized and surfactantextracted MSNPs have a negligible concentration of threemembered rings. 39 For amorphous silica nanoparticles in general, dissolution results in monosilicic acid or oligosilicic acid, which have been shown to have no intrinsic toxicity. 49 Although based on numerous recent studies, it is generally observed that MSNPs have much lower toxicity than corresponding nonporous silica colloids (St € ober silica or LUDOX), presumably due to the mesoporosity reducing the effective MSNP/membrane contact area; conclusions concerning the role of particle size, shape, and charge are mixed. Notably Slowing et al. 43 report reduced hemolysis of red blood cells, whereas Lin and Haynes 7 report increased hemolysis with decreasing MSNP sizes over the range 25À260 nm diameters. Toxicity effects are also reported to be highly cell specific. Yu et al. 42 show RAW264.7 macrophage cells to be more sensitive to ∼115 nm solid or MSNPs than A549 cells, especially at very high doses of 250À500 μg/mL, and that solid St € ober silica colloids were more toxic and taken up into macrophage cells to a much greater extent than the corresponding MSNPs. Rationalization and unification of these varied findings requires a detailed understanding of possible internalization pathways. For endocytosis, membrane curvature arguments discussed above indicate that individual 50À60 nm diameter NPs should be most efficiently internalized as shown experimentally for targeted MSNPs. 19 Using spherical and rod-shaped MSNPs, Meng et al. 50 showed for HeLa and A549 cells that particle shape (aspect ratio) is actively sensed and can stimulate efficient NP uptake by macropinocytosis in which multiple NPs are incorporated at once within pinosomes. Toxicity associated with both membrane damage and the fate of endocytosed or pinocytosed MSNPs must be clearly established, and the role of NP aggregation on effective particle shape and membrane association or internalization must be elucidated. In an effort to benchmark MSNP toxicity against control NPs, Figure 8 compares oxidative stress and cell viability Additionally when considering drug delivery, we must bear in mind potential therapeutically administered doses. For example, for the hepatocellular carcinoma cell line Hep3B, the LC 50 and LC 90 values of free DOX are 150 ng/mL and 500 ng/mL, respectively. Those quantities could be delivered in 400 ng/mL and 1.3 ug/mL of MSNPs. As shown by Ashley et al., 19 when using targeted MSNPs, these values fall to 6 ng/mL and 20 ng/mL due to the MSNP capacity, stability, and internalization efficiency. If only a few percent of MSNP are delivered to the tumor microenvironment, relevant concentrations for the study of MSNP toxicity are less than about 100 μg/mL, where most studies have shown insignificant toxicity.
Future Directions
The multifunctional modular design of MSNPs shown in Figure 1 suggests next generation nanocarriers where multicomponent cargos are delivered to target cells through the active recruitment of targeting ligands combined with biologically triggered responses that actuate molecular valves. The combination of molecular machines and increasingly complex and biomimetic SLBs, for example, those derived from red blood cells, 52 may allow unprecedented engineering of NP/cellular interactions and provide a universal platform for theranostics and personalized medicine. 
